Lipoprotein-associated phospholipase A2: Review of its role as a marker and a potential participant in coronary endothelial dysfunction

Shahar Lavi, Ronit Lavi, Joseph P. McConnell, Lilach O Lerman, Amir Lerman

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

The role of inflammation in atherosclerosis continues to emerge. Lipoprotein-associated phospholipase A2 (Lp-PLA2), a novel plasma biomarker, circulates in the blood bound mainly to low-density lipoprotein (LDL) and promotes vascular inflammation. Several epidemiological studies have shown that circulating levels of Lp-PLA2 are an independent risk factor for cardiovascular events. Recent studies demonstrate that Lp-PLA2 is also associated with endothelial dysfunction and early atherosclerosis. This review provides an overview of these studies, suggests plausible mechanisms for the association between endothelial dysfunction and Lp-PLA2, and highlights future potential therapies.

Original languageEnglish (US)
Pages (from-to)219-226
Number of pages8
JournalMolecular Diagnosis and Therapy
Volume11
Issue number4
StatePublished - 2007

Fingerprint

1-Alkyl-2-acetylglycerophosphocholine Esterase
Atherosclerosis
Inflammation
LDL Lipoproteins
Lipoproteins
Blood Vessels
Epidemiologic Studies
Biomarkers

ASJC Scopus subject areas

  • Genetics
  • Molecular Medicine
  • Medicine(all)
  • Pharmacology

Cite this

Lipoprotein-associated phospholipase A2 : Review of its role as a marker and a potential participant in coronary endothelial dysfunction. / Lavi, Shahar; Lavi, Ronit; McConnell, Joseph P.; Lerman, Lilach O; Lerman, Amir.

In: Molecular Diagnosis and Therapy, Vol. 11, No. 4, 2007, p. 219-226.

Research output: Contribution to journalArticle

@article{5e458972e5b64689a780fdc972cebe4d,
title = "Lipoprotein-associated phospholipase A2: Review of its role as a marker and a potential participant in coronary endothelial dysfunction",
abstract = "The role of inflammation in atherosclerosis continues to emerge. Lipoprotein-associated phospholipase A2 (Lp-PLA2), a novel plasma biomarker, circulates in the blood bound mainly to low-density lipoprotein (LDL) and promotes vascular inflammation. Several epidemiological studies have shown that circulating levels of Lp-PLA2 are an independent risk factor for cardiovascular events. Recent studies demonstrate that Lp-PLA2 is also associated with endothelial dysfunction and early atherosclerosis. This review provides an overview of these studies, suggests plausible mechanisms for the association between endothelial dysfunction and Lp-PLA2, and highlights future potential therapies.",
author = "Shahar Lavi and Ronit Lavi and McConnell, {Joseph P.} and Lerman, {Lilach O} and Amir Lerman",
year = "2007",
language = "English (US)",
volume = "11",
pages = "219--226",
journal = "Molecular Diagnosis and Therapy",
issn = "1177-1062",
publisher = "Adis International Ltd",
number = "4",

}

TY - JOUR

T1 - Lipoprotein-associated phospholipase A2

T2 - Review of its role as a marker and a potential participant in coronary endothelial dysfunction

AU - Lavi, Shahar

AU - Lavi, Ronit

AU - McConnell, Joseph P.

AU - Lerman, Lilach O

AU - Lerman, Amir

PY - 2007

Y1 - 2007

N2 - The role of inflammation in atherosclerosis continues to emerge. Lipoprotein-associated phospholipase A2 (Lp-PLA2), a novel plasma biomarker, circulates in the blood bound mainly to low-density lipoprotein (LDL) and promotes vascular inflammation. Several epidemiological studies have shown that circulating levels of Lp-PLA2 are an independent risk factor for cardiovascular events. Recent studies demonstrate that Lp-PLA2 is also associated with endothelial dysfunction and early atherosclerosis. This review provides an overview of these studies, suggests plausible mechanisms for the association between endothelial dysfunction and Lp-PLA2, and highlights future potential therapies.

AB - The role of inflammation in atherosclerosis continues to emerge. Lipoprotein-associated phospholipase A2 (Lp-PLA2), a novel plasma biomarker, circulates in the blood bound mainly to low-density lipoprotein (LDL) and promotes vascular inflammation. Several epidemiological studies have shown that circulating levels of Lp-PLA2 are an independent risk factor for cardiovascular events. Recent studies demonstrate that Lp-PLA2 is also associated with endothelial dysfunction and early atherosclerosis. This review provides an overview of these studies, suggests plausible mechanisms for the association between endothelial dysfunction and Lp-PLA2, and highlights future potential therapies.

UR - http://www.scopus.com/inward/record.url?scp=34548433511&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34548433511&partnerID=8YFLogxK

M3 - Article

C2 - 17705576

AN - SCOPUS:34548433511

VL - 11

SP - 219

EP - 226

JO - Molecular Diagnosis and Therapy

JF - Molecular Diagnosis and Therapy

SN - 1177-1062

IS - 4

ER -